Cyclerion Therapeutics Inc. (NASDAQ: CYCN) Expands its Partnership With Beacon Biosignals

July 26, 2021

Cyclerion Therapeutics Inc. (NASDAQ: CYCN) has announced an expansion and extended its strategic partnership with Beacon Biosignals. The partnership will identify disease-relevant biomarkers refining patient selection as well as endpoints to guide Cyclerion’s clinical development of experimental therapies for cognitive impairment-related neurological diseases. Cyclerion to leverage Beacon Biosignals’ EEG tech The EEG neurobiomarker technology from Beacon Biosignals is designed to find and scale novel therapeutic models for psychiatric and neurological…